Company name
Genevant Sciences
Company profile
Genevant Sciences is a leading nucleic acid delivery solutions company with best-in-class lipid nanoparticle (LNP) technology and next generation ligand conjugate technology. Our selective collaboration business model enables us to partner with innovative payload companies in the gene editing, and RNA editing, therapeutic and vaccine spaces to bring emerging technologies into and through the clinic.
Date, time and room information
Monday, May 4, 15:30 - 15:45, room Montreal
Category
Clinical stage development company
Title of the presentation
Innovative LNP Delivery Expands the Reach of Nucleic Acid Therapeutics
Speaker information
| Name | Position | Institution |
|---|---|---|
| Ed Yaworski | Chief Technology Officer | Genevant Sciences |
